These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 12119805

  • 1. Drugs and children.
    Pinkham JR.
    ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805
    [No Abstract] [Full Text] [Related]

  • 2. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

  • 3. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
    Ghanizadeh A.
    Acta Ophthalmol; 2010 Mar 30; 88(2):e56. PubMed ID: 19508459
    [No Abstract] [Full Text] [Related]

  • 4. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Jun 30; (7):262-71. PubMed ID: 12230649
    [No Abstract] [Full Text] [Related]

  • 5. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
    Diller LH.
    Hastings Cent Rep; 1996 Jun 30; 26(2):12-8. PubMed ID: 8722521
    [No Abstract] [Full Text] [Related]

  • 6. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Dec 30; (8):280-90. PubMed ID: 12603883
    [No Abstract] [Full Text] [Related]

  • 7. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 30; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131
    [Abstract] [Full Text] [Related]

  • 9. [Malnutrition in children with DAMP?].
    Andersen LL.
    Ugeskr Laeger; 2009 Mar 02; 171(10):824. PubMed ID: 19280776
    [No Abstract] [Full Text] [Related]

  • 10. Methylphenidate euphoria.
    Corrigall R, Ford T.
    J Am Acad Child Adolesc Psychiatry; 1996 Nov 02; 35(11):1421. PubMed ID: 8936903
    [No Abstract] [Full Text] [Related]

  • 11. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 12. Explosive outbursts associated with methylphenidate.
    Adrian N.
    J Am Acad Child Adolesc Psychiatry; 2001 Jun 23; 40(6):618-9. PubMed ID: 11392335
    [No Abstract] [Full Text] [Related]

  • 13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep 23; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 14. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C.
    Rev Infirm; 2009 Jun 23; (151):47-9. PubMed ID: 19579855
    [No Abstract] [Full Text] [Related]

  • 15. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.
    Psychiatr Pol; 2009 Jun 23; 43(2):183-92. PubMed ID: 19697788
    [Abstract] [Full Text] [Related]

  • 16. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 23; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

  • 17. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun 19; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract] [Full Text] [Related]

  • 18. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA.
    Arch Gen Psychiatry; 2007 Feb 19; 64(2):218-24. PubMed ID: 17283289
    [Abstract] [Full Text] [Related]

  • 19. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC, Cox DJ.
    J Psychopharmacol; 2008 May 19; 22(3):227-9. PubMed ID: 18541623
    [No Abstract] [Full Text] [Related]

  • 20. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R, Gross-Tsur V.
    Harefuah; 1997 May 01; 132(9):672-5. PubMed ID: 9225587
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.